Literature DB >> 16311689

[Consensus: Rational approach towards the patient with cancer, fever and neutropenia].

María Elena Santolaya1, Ricardo Rabagliati, Teresa Bidart, Ernesto Payá, Ana M Guzmán, Ricardo Morales, Stephanie Braun, Lucía Bronfman, Marcela Ferrés, Claudio Flores, Patricia García, Luz M Letelier, Bárbara Puga, Carmen Salgado, Luis Thompson, Juan Tordecilla, Marcela Zubieta.   

Abstract

The severity and duration of post chemotherapy neutropenia were recognized during the 1960s as main predisposing factors for infections in cancer patients. At the beginning of the 70's a standard management approach for all febrile neutropenia (FN) episodes was proposed, based on hospitalization and intravenous empirical broad spectrum antibiotic therapy. Widespread use of this approach resulted in a significant reduction in mortality attributable to bacterial infections. During the last 10 to 15 years, reappraisal of this standard approach has been done by several research groups who question the benefit of treating all FN patients similarly without taking in to consideration differences in severity of the FN episodes. This reappraisal has led during the 1990s to the development of the concept of high and low risk FN episodes that has been the base for the adoption of selective therapies based on the risk categorization of the individual patient. The Chilean Infectious Diseases Society called upon two government National Programs responsible for the appropriate distribution of chemotherapeutic drugs to all pediatric and adults cancer patients within the public health system, and upon the Chilean Hematology Society for the development of a Consensus on Diagnosis, Treatment and Prevention of Infections during FN Episodes in Cancer patients. The need for this Consensus is based on two main aspects: the new approaches proposed during the past year for management of these episodes, and the increasing population of cancer patients receiving improved chemotherapeutic agents that has increased there survival possibilities as well as there possibility to suffer a FN episode. The topics discussed in this document are based on an updated systematic and analytic review of the medical literature including epidemiology, laboratory diagnostics, risk categorization, treatment and prophylaxis. National data was included when available in order to provide the healthcare personnel that take care of these patients with best evidence based recommendations adjusted to the Chilean reality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311689     DOI: /S0716-10182005000500001

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  5 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital.

Authors:  Husnia Bedewi Mohammed; Malede Berihun Yismaw; Atalay Mulu Fentie; Tamrat Assefa Tadesse
Journal:  BMC Res Notes       Date:  2019-08-20

3.  Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.

Authors:  K Bochennek; A Hassler; C Perner; J Gilfert; S Schöning; T Klingebiel; D Reinhardt; U Creutzig; T Lehrnbecher
Journal:  Blood Cancer J       Date:  2016-01-15       Impact factor: 11.037

4.  Guidance Statement for the Management of Febrile Neutropenia in Pediatric Patients Receiving Cancer-Directed Therapy in Central America and the Caribbean.

Authors:  Mario Melgar; Tea Reljic; Guillermo Barahona; Kattia Camacho; Alicia Chang; Johanny Contreras; Darrell Espinoza; Dora Estripeaut; Mario Gamero; Marco Luque; Girlande Mentor; Pamela Zacasa; Maysam Homsi; Miguela A Caniza; Ambuj Kumar; Sheena Mukkada
Journal:  JCO Glob Oncol       Date:  2020-03

5.  Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America.

Authors:  Mario A Melgar; Maysam R Homsi; Brooke Happ; Yin Su; Li Tang; Miriam L Gonzalez; Miguela A Caniza
Journal:  Support Care Cancer       Date:  2021-06-30       Impact factor: 3.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.